INKON Life Technology Co., Ltd. Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next
Apr 23
Chinese (SSE) Healthcare Services Industry Analysis
UpdatedApr 24, 2024
DataAggregated Company Financials
Companies40
- 7D1.9%
- 3M-4.5%
- 1Y-32.4%
- YTD-15.0%
The Healthcare Services is pretty flat in the last 7 days, but Huadong Medicine has stood out, gaining 12%. Unfortunately though, the industry is down 33% over the past 12 months. Looking forward, earnings are forecast to grow by 26% annually.
Industry Valuation and Performance
Has the Chinese Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 24 Apr 2024 | CN¥569.0b | CN¥986.0b | CN¥20.9b | 29x | 27.2x | 0.6x |
| Fri, 22 Mar 2024 | CN¥620.8b | CN¥980.4b | CN¥20.3b | 30x | 30.6x | 0.6x |
| Sun, 18 Feb 2024 | CN¥604.2b | CN¥977.8b | CN¥20.1b | 29.1x | 30.1x | 0.6x |
| Tue, 16 Jan 2024 | CN¥636.6b | CN¥976.7b | CN¥19.7b | 28.5x | 32.3x | 0.7x |
| Thu, 14 Dec 2023 | CN¥692.5b | CN¥976.1b | CN¥19.9b | 33.7x | 34.8x | 0.7x |
| Sat, 11 Nov 2023 | CN¥730.9b | CN¥976.1b | CN¥19.9b | 32.1x | 36.7x | 0.7x |
| Mon, 09 Oct 2023 | CN¥733.8b | CN¥982.2b | CN¥21.2b | 29.8x | 34.6x | 0.7x |
| Wed, 06 Sep 2023 | CN¥731.2b | CN¥982.2b | CN¥21.2b | 29.5x | 34.5x | 0.7x |
| Fri, 04 Aug 2023 | CN¥767.5b | CN¥954.7b | CN¥23.1b | 25.8x | 33.2x | 0.8x |
| Sun, 02 Jul 2023 | CN¥781.5b | CN¥948.1b | CN¥23.0b | 26.4x | 34x | 0.8x |
| Tue, 30 May 2023 | CN¥828.6b | CN¥948.0b | CN¥23.0b | 27.4x | 36.1x | 0.9x |
| Thu, 27 Apr 2023 | CN¥827.2b | CN¥928.4b | CN¥25.8b | 28.7x | 32.1x | 0.9x |
| Sat, 25 Mar 2023 | CN¥823.6b | CN¥906.1b | CN¥26.8b | 29.7x | 30.7x | 0.9x |
| Mon, 20 Feb 2023 | CN¥854.4b | CN¥906.0b | CN¥26.4b | 31.5x | 32.4x | 0.9x |
| Wed, 18 Jan 2023 | CN¥855.7b | CN¥906.0b | CN¥26.4b | 30x | 32.4x | 0.9x |
| Fri, 16 Dec 2022 | CN¥804.1b | CN¥905.7b | CN¥26.4b | 29.3x | 30.5x | 0.9x |
| Sun, 13 Nov 2022 | CN¥752.7b | CN¥905.7b | CN¥26.4b | 31.6x | 28.5x | 0.8x |
| Tue, 11 Oct 2022 | CN¥641.0b | CN¥842.5b | CN¥23.8b | 21x | 26.9x | 0.8x |
| Thu, 08 Sep 2022 | CN¥669.4b | CN¥842.5b | CN¥23.8b | 24.5x | 28.1x | 0.8x |
| Sat, 06 Aug 2022 | CN¥716.7b | CN¥832.8b | CN¥22.6b | 34.1x | 31.8x | 0.9x |
| Mon, 04 Jul 2022 | CN¥758.3b | CN¥839.0b | CN¥23.9b | 26.4x | 31.7x | 0.9x |
| Wed, 01 Jun 2022 | CN¥683.3b | CN¥839.0b | CN¥23.9b | 25.3x | 28.5x | 0.8x |
| Fri, 29 Apr 2022 | CN¥636.8b | CN¥832.7b | CN¥25.5b | 23.2x | 25x | 0.8x |
| Sun, 27 Mar 2022 | CN¥667.0b | CN¥816.3b | CN¥27.6b | 27.1x | 24.2x | 0.8x |
| Tue, 22 Feb 2022 | CN¥668.7b | CN¥806.8b | CN¥26.8b | 27.6x | 25x | 0.8x |
| Thu, 20 Jan 2022 | CN¥699.6b | CN¥805.6b | CN¥26.7b | 25.7x | 26.2x | 0.9x |
| Sat, 18 Dec 2021 | CN¥741.2b | CN¥804.6b | CN¥26.6b | 23.2x | 27.9x | 0.9x |
| Mon, 15 Nov 2021 | CN¥751.5b | CN¥802.0b | CN¥26.5b | 23.1x | 28.3x | 0.9x |
| Wed, 13 Oct 2021 | CN¥798.3b | CN¥793.2b | CN¥27.2b | 24.4x | 29.3x | 1x |
| Fri, 10 Sep 2021 | CN¥738.5b | CN¥791.7b | CN¥27.1b | 22.9x | 27.3x | 0.9x |
| Sun, 08 Aug 2021 | CN¥854.3b | CN¥791.5b | CN¥27.0b | 26.1x | 31.6x | 1.1x |
| Sat, 01 May 2021 | CN¥939.3b | CN¥756.8b | CN¥25.2b | 28.4x | 37.3x | 1.2x |
Price to Earnings Ratio
37.3x
Current Industry PE
- Investors are relatively neutral on the Chinese Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 31.1x.
- The industry is trading close to its 3-year average PS ratio of 0.87x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 7.0% per year over the last three years.
- Meanwhile revenues for these companies have grown 9.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | 1.63% | |
| Healthcare | 2.94% | |
| Healthcare Services | 1.94% | |
| Healthcare Distributors | 3.12% | |
| Healthcare Facilities | 1.41% | |
| Managed Healthcare | 0% | |
| Healthcare Services | -1.18% | |
Industry PE
- Investors are most optimistic about the Healthcare Facilities industry even though it's trading below its 3-year average PE ratio of 257x.
- Analysts are expecting annual earnings growth of 33.3%, which is higher than its past year's earnings growth of 25.1% per year.
- Investors are most pessimistic about the Healthcare Distributors industry, although it looks like investor sentiment has improved given that it's trading above its 3-year average of 18.0x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 39% over the next 5 years.
- This is better than its past earnings decline of 22% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 17% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 963 Huadong Medicine | CN¥32.40 | 7.8% +CN¥4.1b | -20.8% | PE20x | |
| 301293 Sanbo Hospital Management Group | CN¥61.05 | 11.5% +CN¥996.7m | n/a | PE123.6x | |
| 601607 Shanghai Pharmaceuticals Holding | CN¥17.75 | 1.0% +CN¥666.6m | -19.2% | PE17.4x | |
| 28 China National Accord Medicines | CN¥34.95 | 2.8% +CN¥528.7m | -23.6% | PE12.2x | |
| 600211 Tibet Rhodiola Pharmaceutical Holding | CN¥47.48 | 3.6% +CN¥414.1m | -18.9% | PE14.7x |
